What was studied?
Seventy-two participants with major depressive disorder completed a reward-learning task before and after a randomized sixteen-week study.
What did the researchers report?
Computational analysis found changes in choosing higher-expected-reward options and repeating previous choices in the semaglutide group.
What are the limits?
Task behavior is not the same endpoint as depression remission or improved daily functioning. This secondary analysis does not establish a psychiatric indication or support self-directed use.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.